Title : High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease.

Pub. Date : 2018 Aug

PMID : 29288514






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: A 12-week regimen of OBV/PTV/r +- DSV with or without RBV is highly effective with a favourable safety profile amongst GT4 and GT1 patients with CKD stages 4-5. Ribavirin beta-1,4-galactosyltransferase 1 Homo sapiens